Merck will build a 69-acre semiconductor materials manufacturing complex in Zhangjiagang, China. The project will include plants to produce thin-film materials and special gases for electronics, as well as warehouses and operations centers. The company previously said it planned to spend $82.6 million to build the new base in Zhangjiagang.

Merck will invest about €440 million to expand membrane production at its Carrigtwohill plant and build a new production facility in Blarney Business Park, Ireland. The expansion at the plant includes €290 million for the construction of an immersion membrane casting facility for gene therapy and virus sterilization. A new €150 million specialty filter facil...

Merck's IFRS net income for 3 months of 2022 was €884 million, up 18.2% from €748 million in the previous year. Revenue increased by 12.2% to €5.198 billion compared to €4.631 billion a year earlier.

Merck has completed its acquisition of Exelead for $780 million. The company specializes in the development and production of complex injectable drugs and lipid nanoparticle-based drug delivery technologies, which is key in the mRNA therapy of Covid-19 and many other diseases.